Diseases, Conditions, Syndromes

TGen and ABL pursue global rollout of advanced TB test

In an important step toward eradicating tuberculosis (TB), the Translational Genomics Research Institute (TGen), an affiliate of City of Hope, has signed a licensing agreement with an international biomedical firm, Advanced ...

Oncology & Cancer

Brazilian antibody will be used to create new cancer drug

Recepta Biopharma, a Brazilian company, has signed a licensing agreement with Mersana Therapeutics, under which the US-based company's technology will be used to produce a monoclonal antibody (mAb) that can be deployed for ...

Diseases, Conditions, Syndromes

Novartis licences drugs to non-profit TB group

Swiss-based pharmaceuticals giant Novartis said Wednesday that it had signed a licensing deal with an international organisation that fights tuberculosis.

Medical research

New therapy to stop progression of fibrosis

Scientists from the University of Sheffield have developed a novel antibody-based therapy which targets the progression of life threating kidney fibrosis.


NCAA football exploits players in 'invisible labor market'

College football exploits players in an "invisible labor market," and the only plausible way for student-athletes to address their interests is the credible threat of unionization, according to research from a University ...